Skip to content

Pulse Biosciences, Inc. PLSE Operating Lease Right-of-Use Assets in Other Assets

Operating Lease Right-of-Use Assets in Other Assets at other companies

Abbott logo
AbbottABT
Boston Scientific logo
Boston ScientificBSX
Merit Medical Systems logo
Merit Medical SystemsMMSI
ITG
Integer HoldingsITGR
LivaNova logo
LivaNovaLIVN
Capricor Therapeutics logo
Capricor TherapeuticsCAPR

Other financials

Income statement

See full
Revenue$401.0K
Gross profit$31.0K
Operating income-$19.2M-6.1%
Net income-$18.6M-10.6%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$68.3M-42.7%
Total debt$7.2M-16.6%
Total equity$66.3M-44.0%
Total assets$81.6M-38.8%

Cash flow

See full
Operating cash flow-$14.6M-7.9%
CapEx$33.0K-26.7%
Free cash flow-$14.6M-7.8%

Valuation

See full
Market cap$1.77B+38.4%

Profitability

See full
Gross margin-4,067.5%
Operating margin-10,392.1%
Net margin-9,929%
FCF margin-7,390%

Returns & leverage

See full
Return on equity-80.7%+3.1pp
Debt / equity0.1×0.0×
Current ratio7.3×-8.3×

Where this comes from

Reported directly by Pulse Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s operating lease right-of-use assets in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulse Biosciences, Inc.'s operating lease right-of-use assets in other assets?
Pulse Biosciences, Inc. (PLSE) reported operating lease right-of-use assets in other assets of $5.7M in Q1 2026.
How has Pulse Biosciences, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
Pulse Biosciences, Inc.'s operating lease right-of-use assets in other assets decreased by 17.2% year-over-year, from $6.89M to $5.7M.
What is the long-term trend for Pulse Biosciences, Inc.'s operating lease right-of-use assets in other assets?
Over 5 years (2020 to 2025), Pulse Biosciences, Inc.'s operating lease right-of-use assets in other assets has grown at a -8.6% compound annual growth rate (CAGR), from $9.44M to $6.01M.